Insider Selling: Oncimmune Holdings plc (ONC.L) (LON:ONC) Insider Sells 10,000 Shares of Stock

Oncimmune Holdings plc (ONC.L) (LON:ONC) insider Cheung To sold 10,000 shares of Oncimmune Holdings plc (ONC.L) stock in a transaction on Friday, January 8th. The shares were sold at an average price of GBX 185 ($2.42), for a total value of £18,500 ($24,170.37).

Cheung To also recently made the following trade(s):

• On Monday, January 11th, Cheung To sold 40,000 shares of Oncimmune Holdings plc (ONC.L) stock. The shares were sold at an average price of GBX 185 ($2.42), for a total value of £74,000 ($96,681.47).

Shares of ONC stock opened at GBX 189 ($2.47) on Thursday. The firm has a market cap of £120.32 million and a price-to-earnings ratio of -14.10. Oncimmune Holdings plc has a 12 month low of GBX 30 ($0.39) and a 12 month high of GBX 200 ($2.61). The company has a quick ratio of 1.74, a current ratio of 1.80 and a debt-to-equity ratio of 375.32. The stock has a 50-day moving average price of GBX 169.49 and a 200 day moving average price of GBX 154.75.

About Oncimmune Holdings plc (ONC.L)

Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases.

Read More: Special Purpose Acquisition Company (SPAC) – What You Need to Know